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Abstract 
Background: Provider-centered factors contribute to unexplained variation in the quality of death. 
The relationship between health care providers and patients, bidirectional communication, and 
consistency of longitudinal care planning are important provider-centered factors. 
Objective: To explore whether the level of trust in health care providers, the quality of continuity of 
care, and the level of coordination of care among home health care providers are associated with the 
quality of death for cancer patients dying at home. 
Design: This study was a part of a nationwide multicenter questionnaire survey of bereaved family 
members of cancer patients evaluating the quality of end-of-life care in Japan. 
Setting/Subjects: We investigated 702 family members of cancer patients who died at home. 
Measurements: The quality of death was evaluated from 9 core domains of the short version of the 
Good Death Inventory (GDI). We measured 5 factors on a Likert scale, including patient and family 
trust in health care providers, continuity of care by home hospice and hospital physicians, and 
coordination of care among home hospice staff. 
Results: A total of 538 responses (77%) were obtained and 486 responses were analyzed. Trust in 
health care providers was correlated with the GDI score (r = 0.300~0.387, p<0.001). The quality of 
care coordination was associated with the GDI score (r = 0.242, p<0.001). 
Conclusions: Trust of the patient and family in home hospice staff, as well as coordination of care 
among hospice staff, are associated with the quality of death for cancer patients dying at home. 
 
Key Words: Quality of death, trust in health care providers, continuity of care, coordination of care, 
patients with advanced cancer, home care 
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 Introduction 
When patients have advanced cancer, achieving a good quality of death (QOD) is an important 
issue for patients, family members, and health care providers (HCPs). Although, several factors 
related to QOD have been reported 1,2, a recent longitudinal cohort study on the factors related to 
QOD pointed out that the vast majority of the variance in QOD remains unexplained and several 
patient-centered and provider-centered factors are thought to contribute to this unexplained 
variance1,3.  
Bidirectional communication between health care providers and patients, their overall relationship, 
and consistency of longitudinal care planning are typical provider-centered factors that could be 
modified to improve QOD. Therefore, it is worth exploring bidirectional communication between 
health care providers and patients, as well as their overall relationship and consistency of 
longitudinal care planning, in patients with advanced cancer3. Dying at home is thought of as the 
most valuable factor in determining QOD for the patient and family4,5, so it is worth exploring 
provider-centered factors related to QOD in the home care setting, which could also be applied to 
improving the quality of health care in other settings. 
Bidirectional communication between health care providers and patients and their overall 
relationship are exemplified by trust and rapport, and make an essential contribution to QOD in 
patients with advanced cancer6,7. Several previous studies have indicated that trust in the physician 
 reduces the anxiety of patients8,9, improves decision making10–12, and increases adherence to the 
oncologist’s recommendations13–15.  
Consistency of longitudinal care requires both coordination and continuity of care. Coordination 
of care has attracted considerable attention as a measure of cancer care quality, and access to 
well-coordinated end-of-life care in all settings is advocated by international policy standards16–18. 
Specific areas of concern with regard to continuity of specialist care have emerged since the late 
1980s, including the care of patients with HIV/AIDS, cardiovascular disease, and cancer, reflecting 
the increased complexity of managing chronic disease, with continuity being regarded as an 
important component of end-of-life care for multidisciplinary professionals19. 
Against this background, the objectives of the present study were to explore whether the quality of 
trust of the patient and family in health care providers, the quality of continuity of care, and the 
quality of coordination of care among health care providers were associated with QOD in patients 
with advanced cancer receiving home care.  
 
Methods 
This study was part of a nationwide survey of bereaved family members of cancer patients that 
evaluated the quality of end-of-life care in Japan (the Japan Hospice and Palliative care Evaluation 
study 3: J-HOPE3)20, which was a multicenter questionnaire survey of bereaved family members of 
 cancer patients who died at hospital, in palliative care units, or at home. The present study was a 
subanalysis of the main study that focused on bereaved family members of cancer patients who died 
at home. 
We mailed anonymous questionnaires to the bereaved families in May 2014, and mailed 
questionnaires again to the non-responding families in June 2014. Completion and return of the 
questionnaire was regarded as indicating consent to participation in this study, and families who did 
not want to participate were asked to return the questionnaire with “no reply.” Ethical and scientific 
validity was confirmed by the institutional review boards of all participating institutions, and this 
study was approved by the institutional review boards of Tohoku University and the other 
participating institutions. 
 
Participating Institutions  
We recruited participating institutions from the 51 home hospice services that were members of 
Hospice Palliative Care Japan (HPCJ) prior to 1 July 2013. We sent letters to these 51 institutions 
and 22 participated in the study.  
 
Participants and procedures 
A cross-sectional, anonymous, self-reported questionnaire survey was conducted between May and 
July 2014. We asked each institution to identify and list up to 80 bereaved family members of 
 patients who had died prior to 31 January 2014. The inclusion criteria were as follows: (1) the 
patient died of cancer, (2) the patient was aged 20 years or older, and (3) the bereaved family 
member was aged 20 years or older. The exclusion criteria were as follows: (1) the patient received 
palliative care for less than 3 days; (2) the bereaved family member could not be identified; (3) 
terminal treatment or death occurred in an intensive care unit; (4) the candidate participant had 
severe psychological distress as determined by the primary care physician and nurses; and (5) the 
candidate participant was incapable of completing the self-reported questionnaire because of 
cognitive impairment or visual disability. The questionnaire was sent to the bereaved family 
members identified by each participating institution along with an explanation of the survey and 
return of the completed questionnaire was regarded as indicating consent to the study. We asked 
participants to return the completed questionnaire to the study secretariat office (Tohoku University) 
within 2 weeks. We sent a reminder to non-responders after 1 month. If they did not wish to 
participate in the study, they were asked to check a ‘‘no participation’’ box and return the incomplete 
questionnaire.  
 
 Good Death Inventory - short version 
We evaluated the 9 core domains of the short version of the Good Death Inventory (GDI) as the 
primary endpoint (freedom from physical and psychological discomfort, staying in a favorite place, 
maintaining hope and pleasure, not being a burden to others, spending time with the family, 
maintaining independence, living in a comfortable environment, being respected as an individual, 
and fulfillment at the end of life; range of the total score: 9 to 63 points). The short version of the 
GDI was developed on the basis of qualitative interviews and a large-scale quantitative study21–23. 
The original version of the GDI has 10 core domains and 8 optional domains, with a total of 54 items. 
The 10 core domains evaluate items that Japanese people consistently rate as important, while the 8 
optional domains evaluate items that are only sometimes considered to be important depending upon 
individual values22,24. The short version of the GDI consists of 18 items (one for each domain), and 
its validity and reliability have been confirmed22.We deleted one core domain of the GDI (trusting 
health care staff), because we assessed trust of the patient and family in HCPs as an explanatory 
variable. We asked participants “How do you think the patient felt during the end-of-life period? 
Please write the appropriate number next to each statement.” and then asked each question, e.g., “Do 
you think the patient was free from physical distress.” 
Participants evaluated each domain by using a 7-point Likert-type scale (1: strongly disagree to 7: 
strongly agree). The total score was calculated by summing the scores for all items, with a high total 
 score indicating a good death. 
 Questionnaire  
Because of the lack of an existing specific tool for evaluating the opinions of bereaved family 
members about trust of the patient and family in health care providers, continuity of care, and 
coordination of care among health care providers, we developed an original questionnaire on the 
basis of a literature review and discussion among the authors of this study25–29. We measured the 
level of patient and family trust in health care providers, the quality of continuity of care, and the 
level of coordination of care among health care providers on a 6-point Likert-type scale (1: strongly 
disagree to 6: strongly agree). Patient and family trust in health care providers was assessed by 
investigating three factors (Appendix 1), which were patient and family trust in the oncologist (four 
items), patient and family trust in the home hospice physician (four items), and patient and family 
trust in the home hospice nurses (four items). Quality of continuity of care by health care providers 
was classified into two factors (Appendix 1), which were quality of continuity of care by the home 
hospice physicians and hospital physicians or by the home hospice staff and hospital staff (two 
items). The quality of coordination of care among health care providers was classified into two 
factors (Appendix 1), which were coordination of care between the home hospice physician and 
home hospice nurse or coordination between the care manager and home hospice nurse (two items). 
Internal consistency of these subcategories was confirmed by explanatory factor analysis and 
calculation of Cronbach’s α, showing that internal consistency was acceptable for all subcategories 
 (Cronbach’s α=0.79 to 0.89).  
The primary palliative care physicians recorded patient background characteristics (age, sex, 
primary tumor sites, and duration of home care), while the families reported the caregiver’s age, sex, 
and relationship to the patient.  
 
Statistical Analysis 
 We first analyzed the distribution of the each of 9 core domains of the short version of GDI and the 
response rates for each domain (defined as the sum of "somewhat agree", "agree", and "strongly 
agree"). Then we calculated the total score for the 9 core domains of the short version of GDI as the 
GDI score for each participant (range: 9 to 63 points). Subsequently, we investigated coefficients for 
associations and conducted univariate analyses using linear regression. We defined a correlation 
coefficient of less than 0.30 as indicating a negligible correlation, while 0.30 to 0.50 was a weak 
positive correlation, 0.50 to 0.70 was a moderate positive correlation, 0.70 to 0.90 was a strong 
positive correlation, and 0.90 to 1.00 was a very strong positive correlation30. Significance was 
accepted at p<0.05 and analyses were done with SPSS-J software (ver. 22.0; IBM, Tokyo, Japan). 
 
Results 
A total of 791 family members met the inclusion criteria, but 82 were subsequently excluded from 
 analysis (Figure 1). We sent out 702 questionnaires, and 538 questionnaires (77%) were returned. 
Since 52 family members refused to participate, we analyzed a total of 486 responses (90% of the 
returned questionnaires). Characteristics of the participants are summarized in Table 1. The mean 
age of the patients who died was 74.3 ± 11.5 years and 57.8% were men. The most frequent primary 
tumor was lung cancer, followed by hepatobiliary/pancreatic cancer. The duration of home care was 
77.7 ± 150.0 days. The mean age of the bereaved family members was 62.6 ± 11.9 years and 25.9% 
were men. The bereaved person was most frequently the husband/wife of the patient, followed by a 
child of the patient. 
 
Quality of death  
 Agreement rates for the GDI domains are shown in Table 1. The average GDI score was 45.0 ± 7.9. 
The agreement rate (sum of "somewhat agree", "agree", and "strongly agree") was over 80% for the 
following items: “Being able to stay in one’s favorite place”, “Trusting the physician”, “Living in a 
comfortable environment”, and “Being valued as a person”.  
 
Trust in health care providers 
Nearly all of the bereaved family members reported that the home hospice physician (92.5%, 
n=359) and home hospice nurses (95.5%, n=354) were available to consult about their concerns, 
 while 73.9% (n=357) reported that the hospital physician was available to consult about concerns 
(Table 2). Similarly, over 90% of the bereaved family members reported that the home hospice 
physician (91.1%, n=350) and the home hospice nurses (93.7%, n=347) respected the values of the 
patient and family, while 70.4% (n=348) reported that the hospital physician did so (Table 2). In 
addition, the majority of the bereaved family members reported that the home care hospice physician 
(80.1%, n=347) and home hospice nurses (87.2%, n=344) had a comprehensive care approach, while 
only 54.7% (n=344) reported that the hospital physician had a comprehensive approach (Table 2). 
The mean scores for trust in the oncologist, trust in the home hospice physician, and trust in home 
hospice nurses were 4.07 ± 1.21, 4.82 ± 0.93, and 4.97 ± 0.84, respectively (Table 3).  
 
Continuity of care 
Only half of the bereaved family members reported that the hospital staff and home hospice staff 
seemed to be familiar with each other (54.8%, n=336) or that the hospital physician and home 
hospice physician seemed to be familiar with each other (46.0%, n=335) (Table 2). The mean score 
for the quality of continuity of care by home hospice staff and hospital staff was 3.41 ± 1.53 (Table 
3).  
 
Coordination of care 
 Nearly all of the bereaved family members reported that home hospice staff provided care that was 
coordinated and consistent, with the rate being 97.2% (n=353) for coordination between the home 
hospice physician and home hospice nurses or 94.4% (n=342) for coordination between the care 
manager and home hospice nurses (Table 2). The mean score for the level of coordination of care 
among home care hospice staff was 5.02 ± 0.78 (Table 3).  
 
Factors influencing the quality of death  
Associations between various factors and the GDI score are shown in Table 3. There were 
significant weak positive correlations between the GDI score and trust of the patient and family in 
the oncologist, home hospice physician, and home hospice nurses (r = 0.300~0.387, p<0.001). 
Quality of continuity of care showed a negligible association with the GDI score that was not 
significant (r = 0.111, p=0.054), while the quality of coordination of care had a negligible, but 
significant, correlation with the GDI score (r = 0.242, p<0.001). Univariate linear regression 
analyses with adjustment for the patient’s age and sex showed several significant positive 
associations; trust of the patient and family in the home hospice physician had the strongest 
association with the GDI score (p <0.001), followed by trust in the home hospice nurses (p <0.001) 
and quality of coordination of care among home hospice staff (p <0.001). 
 
 Discussion 
To the best of our knowledge, this is the first large-scale study to reveal that bereaved family 
members who reported trust in their HCPs and good coordination of care were more likely to report 
that their loved one experienced good QOD. 
The first important finding of this study was that trust of the patient and family in HCPs (trust in 
each health care provider, availability for consultation about the concerns of family members, 
respect for the values of the patient and family, and a comprehensive care approach) was associated 
with QOD in patients with advanced cancer. This result indicates that bereaved family members who 
reported trust in their HCPs were more likely to report that their loved one experienced good QOD. 
According to a recent study, the therapeutic alliance between patient and oncologist has a positive 
influence on adjustment of caregivers to bereavement that lasts into the early months of 
bereavement6. In addition, a recent systematic review of 36 articles regarding the definition of good 
death indicated that a good relationship with health care providers was an important specific theme 
for good death among patients, family members, and health care providers 31. The conclusions of 
these previous studies were consistent with our findings that trust of the patient and family in health 
care providers based on consideration of patient/family values and psychosocial aspects associated 
with adjustment to bereavement had a positive association with QOD from the perspective of 
bereaved family members.  
 It was noteworthy that trust of the patient and family in the home hospice physician showed a 
stronger association with the GDI score than trust in the oncologist. Similarly, the mean score for 
trust of the patient and family in the home hospice physician was higher than that for trust in the 
oncologist. These were evocative results, because the oncologist generally spends longer with patient 
and family than the home hospice physician. Thus, the chief novel finding of our study was that trust 
between the patient/family and home hospice physician represents a core aspect of high-quality 
end-of-life medical care and contributes to a good death. This implies that the home hospice 
physician should make efforts to maintain good communication with the patient/family regarding 
their concerns, respect patient/family values, provide comprehensive care, and thus earn the trust of 
the patient and family. On the other hand, the relatively low score for trust in oncologists implies that 
the oncologist’s behavior (e.g., consulting about concerns of family members, respecting the values 
of the patient and family, and addressing both daily life and the patient’s physical condition) could 
be modified to improve caregivers' experience of end of life care and subsequent bereavement. 
The second important finding of this study was that perceived continuity of care provided by 
hospital and home hospice staff might not be associated with QOD in patients with advanced cancer. 
Haggerty et al. proposed the classification of continuity into three categories, which are 
informational continuity, relational continuity, and management continuity32. Based on this concept, 
informational continuity corresponds to perceived continuity of the care provided by hospital staff 
 and home hospice staff. Regarding such informational continuity, our results were inconsistent with 
those of a recent large-scale mixed-methods study, which revealed that good communication and 
cooperation among hospital staff and home hospice staff achieved informational continuity with a 
positive effect on daily practice from the perspective of health care providers and an increase of the 
home death rate33. A possible cause of this discrepancy is that it may be difficult for the patient and 
family to recognize the influence of continuity on the quality of care, while other possible causes are 
that the questionnaire might not have adequately explored continuity of care or accurately assessed 
the perspective of bereaved family members. Thus, further investigation will be needed to develop 
adequate tools for assessing perceptions of the patient and family about quality of continuity of care. 
It was noteworthy that bereaved family members reported low score for the perceived continuity of 
care provided by hospital and home hospice staff. This indicated that it was difficult for the patient 
and family to recognize the quality of continuity of care, even though several care processes were 
implemented by each region. Thus, we need to encourage sharing and visualization of continuity 
processes among hospital and home hospice staff. 
The third main finding of this study was that the quality of coordination of care among home 
hospice staff might be associated with the QOD of patients with advanced cancer, although the 
association was weak. This result indicates that bereaved family members who reported good 
coordination of care were more likely to report that their loved ones experienced good QOD. This 
 finding is consistent with the results of a preliminary study showing that shared goals among home 
hospice staff, which are not only directed towards symptom management but also to helping the 
family cope with the death and dying of a loved one, are essential for building an interprofessional 
team34. It is possible that coordination of care only had a weak association with QOD because it is an 
indirect measure, even though coordination of care is required to develop an interprofessional team 
that can assist the family to cope with death and dying and can appropriately support the patient and 
family. Therefore, further research is required to determine how coordination of care by an 
interprofessional team is associates with QOD among patients with advanced cancer. 
The strengths of this study were that it was a large multicenter investigation with a high response 
rate, but there were also several limitations. First, we could not rule out recall bias because of the 
study design. However, several previous studies performed from 3 to 12 months after death of the 
patient have suggested that this may be a reasonable interval in consideration of recall bias and the 
grieving process35–38. Second, our findings were obtained retrospectively from family members, so 
there may have been differences between their perspective and that of the cancer patients39. However, 
this limitation does not necessarily reduce the usefulness of our findings, because Teno et al. noted 
that when measuring end-of-life care outcomes retrospectively, it is important to ask bereaved family 
members to report their own perceptions about the quality of end-of-life care based on direct 
observation, interactions with HCPs, and overall assessment of care40. Third, there were potential 
 biases based on the participants’ state of grief and bereavement; e.g., the overall emotional state 
might affect how participants recalled the end of life of their loved ones, and participants might 
report an overall negative or positive orientation without discriminating between instruments or 
survey items. Thus, we need to interpret the results of this study with caution. 
 
Conclusions 
 Trust of the patient and family in home hospice staff and the quality of coordination of care among 
home hospice staff were associated with QOD for cancer patients dying at home. However, further 
investigation is needed to explore the influence among trust in home hospice staff, coordination of 
care, and the QOD of cancer patients dying at home because our study only demonstrated an 
association. 
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Table 1 Characteristics of the Patients and Caregivers  
  
 
n % 
Patients 
  
 Age (mean ± standard deviation) 74.3 ±11.5 
 
 Sex 
  
   Male 281 57.8  
   Female 205 42.2  
 Primary tumor sites 
  
   Lung 101 20.8  
   Liver, bile duct, pancreas 98 20.2  
   Stomach, esophagus 72 14.8  
   Colon, rectum 66 13.5  
   Prostate, kidney, bladder 37 7.7  
   Uterus, ovary 24 5.0  
   Breast 23 4.7  
   Head and neck, brain 15 3.1  
   Blood 14 2.9  
   Others 36 7.4  
Duration of home care (days) 77.7 ±150.0 
 
Bereaved family members 
  
 Age (mean ± standard deviation) 62.6 ±11.9 
 
 Sex 
  
   Male 126 25.9  
   Female 353 72.6  
 Relationship with the patient 
  
   Husband/wife 254 52.8  
   Child 163 33.9  
   Daughter-in-law or son-in-law 31 6.4  
   Parent 14 2.9  
   Sibling 10 2.1  
   Others 9 1.9  
Good death inventory (mean score ± standard deviation, agreement rate†) 
  
 Being free from physical distress 5.13 ± 1.48 73.1  
 Being able to stay at one’s favorite place 6.08 ± 1.26 89.4  
 Having some pleasure in daily life 4.90 ± 1.55 63.0  
 Not causing problems for others 3.35 ± 1.59 62.2  
 Spending enough time with the family 5.39 ± 1.48 78.7  
 Being dependent in daily activities 3.44 ± 1.87 34.9  
 Living in calm circumstances 5.64 ± 1.23 85.4  
 Being valued as a person 6.12 ± 1.02 95.4  
 Feeling that life is complete 4.87 ± 1.79 61.1  
†Sum of answer "somewhat agree", "agree", and "absolutely agree" 
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